PublizoomAward notice Supplies
Suministro de Imiglucerasa(DOE), Agalsidasa Beta(DOE), Alirocumab(DOE), Sarilumab(DOE), Eliglustat(DOE), Aflibercept(DOE) Intravenoso y Laronidasa(DOE)
Notice published in Spanish. The AI analysis summarises it for you in your language.
- Public buyer
- OSAKIDETZA - Servicio Vasco de Salud - Organización Central
Vitoria-Gasteiz - Place of performance
- Vitoria-Gasteiz
- Estimated value
- €16,775,052 excl. VAT
- Amount awarded
- €13,979,210 excl. VAT
- Planned end of contract
- 29 July 2031
likely re-tender around January 2031 - Bids received
- 1
- Procedure
- Negotiated procedure without prior publication
The buyer consulted a few companies directly: it is no longer possible to take part. - Publication
- 31 July 2026
- Notice language
- Spanish
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Suministro de Imiglucerasa(DOE), Agalsidasa Beta(DOE), Alirocumab(DOE), Sarilumab(DOE), Eliglustat(DOE), Aflibercept(DOE) Intravenoso y Laronidasa(DOE)
Awarded to
7 lots
- 1 - L1_IMIGLUCERASA (DOE)
- 2 - L2_AGALSIDASA BETA (DOE)
- 3 - L3_ALIROCUMAB (DOE)
- 4 - L4_SARILUMAB (DOE)
- 5 - L5_ELIGLUSTAT (DOE)
- 6 - L6_AFLIBERCEPT (DOE) INTRAVENOSO
- 7 - L7_LARONIDASA (DOE)
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33600000
Winning prices for comparable contracts
- A quarter below
- €350,000
- Median
- €846,164
- A quarter above
- €2,267,877
Amounts awarded (excl. VAT) over the last 3 years for 265 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 532851-2026.